chr1-97098577-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000370192.8(DPYD):āc.2678A>Gā(p.Asn893Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,613,222 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Consequence
ENST00000370192.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPYD | NM_000110.4 | c.2678A>G | p.Asn893Ser | missense_variant | 21/23 | ENST00000370192.8 | NP_000101.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPYD | ENST00000370192.8 | c.2678A>G | p.Asn893Ser | missense_variant | 21/23 | 1 | NM_000110.4 | ENSP00000359211.3 | ||
DPYD-AS1 | ENST00000422980.1 | n.64+2591T>C | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250708Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135482
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1460980Hom.: 0 Cov.: 31 AF XY: 0.0000344 AC XY: 25AN XY: 726800
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 31, 2024 | Variant summary: DPYD c.2678A>G (p.Asn893Ser) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 3.7e-05 in 1606262 control chromosomes, predominantly at a frequency of 0.0013 within the East Asian subpopulation in the gnomAD database (v4.1 dataset). In addition, the variant was reported with an allele frequency of 0.0022 (i.e. 235 / 108520 alleles; no homozygotes), in healthy Japanese individuals in the jMorp database (PMID: 33179747). This frequency is close to the estimated maximum expected for a pathogenic variant in DPYD causing Dihydropyrimidine Dehydrogenase Deficiency (0.0025), suggesting that the variant might be benign. The variant, c.2678A>G, has been reported in the literature in Japanese individuals (e.g. Maekawa_2007), and at least two colon cancer patients were described who did not develop severe fluoropyrimidine-related toxicities (Kanai_2023). Publications also reported experimental evidence evaluating an impact on protein function, and demonstrated that the variant resulted in a mild decrease in enzyme activity, corresponding to about 80% residual activity relative to the WT (Offer_2013), while a later study found that the variant N893S exhibited significantly lower activity, corresponding to ~62.8% of the WT (Hishinuma_2018). The following publications have been ascertained in the context of this evaluation (PMID: 17828463, 36524458, 23328581, 29769267, 29152729). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as likely benign. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at